BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11315593)

  • 1. High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas.
    Weckesser M; Matheja P; Rickert CH; Sträter R; Palkovic S; Löttgen J; Kurlemann G; Paulus W; Wassmann H; Schober O
    Eur J Nucl Med; 2001 Mar; 28(3):273-81. PubMed ID: 11315593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
    Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
    Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
    Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
    Schmidt D; Gottwald U; Langen KJ; Weber F; Hertel A; Floeth F; Felsberg J; Reifenberger G; Coenen HH; Müller-Gärtner HW
    Eur J Nucl Med; 2001 Jul; 28(7):855-61. PubMed ID: 11504082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
    Sasaki M; Kuwabara Y; Yoshida T; Nakagawa M; Fukumura T; Mihara F; Morioka T; Fukui M; Masuda K
    Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential scintigraphic strategy for the differentiation of brain tumours.
    Matheja P; Rickert C; Weckesser M; Palkovic S; Löttgen J; Riemann B; Kopka K; Kuwert T; Wassmann H; Paulus W; Schober O
    Eur J Nucl Med; 2000 May; 27(5):550-8. PubMed ID: 10853811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
    Henze M; Mohammed A; Mier W; Rudat V; Dietz A; Nollert J; Eisenhut M; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):324-30. PubMed ID: 12002706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
    Samnick S; Hellwig D; Bader JB; Romeike BF; Moringlane JR; Feiden W; Kirsch CM
    Nucl Med Commun; 2002 Feb; 23(2):121-30. PubMed ID: 11891465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
    Stokkel M; Stevens H; Taphoorn M; Van Rijk P
    Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
    Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
    Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
    Pauleit D; Floeth F; Tellmann L; Hamacher K; Hautzel H; Müller HW; Coenen HH; Langen KJ
    J Nucl Med; 2004 Mar; 45(3):374-81. PubMed ID: 15001676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
    Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
    J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of diagnostic accuracy of (18)F-FDG PET, (123)I-IMT- and (99m)Tc-MIBI SPECT: evaluation of tumour progression in irradiated low grade astrocytomas].
    Henze M; Ozdemir-Sahin N; Hipp P; Mier W; Eisenhut M; Debus J; Haberkorn U
    Nuklearmedizin; 2006; 45(1):49-56. PubMed ID: 16493514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-alpha-methyl tyrosine and single photon emission tomography.
    Dierickx LO; Everaert H; Deron P; Voordeckers M; Lahoutte T; Bossuyt A
    Nucl Med Commun; 2003 Jun; 24(6):633-41. PubMed ID: 12766598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent.
    Weckesser M; Griessmeier M; Schmidt D; Sonnenberg F; Ziemons K; Kemna L; Holschbach M; Langen K; Müller-Gärtner H
    Eur J Nucl Med; 1998 Feb; 25(2):150-6. PubMed ID: 9473263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours.
    Dierckx RA; Martin JJ; Dobbeleir A; Crols R; Neetens I; De Deyn PP
    Eur J Nucl Med; 1994 Jul; 21(7):621-33. PubMed ID: 7957348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of amino acid transport imaging in patients with brain tumors.
    Weckesser M; Matheja P; Schwarzrock A; Rickert CH; Sträter R; Palkovic S; Riemann B; Kopka K; Lüdemann P; Paulus W; Wassmann H; Schober O
    Neurosurgery; 2002 May; 50(5):958-64; discussion 964-5. PubMed ID: 11950398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
    Dierickx LO; Lahoutte T; Deron P; Caveliers V; Vanhove C; Everaert H; Bossuyt A
    Eur J Nucl Med; 2001 Mar; 28(3):282-7. PubMed ID: 11315594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion.
    Borgwardt L; Højgaard L; Carstensen H; Laursen H; Nowak M; Thomsen C; Schmiegelow K
    J Clin Oncol; 2005 May; 23(13):3030-7. PubMed ID: 15860860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.